Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- 20 April 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Liver Disease
- Vol. 11 (4) , 98-104
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (K23HL136891)
This publication has 19 references indexed in Scilit:
- Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisHepatology, 2017
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Liver fibrosis scores predict liver disease mortality in the United States populationHepatology, 2017
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐upHepatology, 2014
- Predictive value of ALT levels for non‐alcoholic steatohepatitis (NASH) and advanced fibrosis in non‐alcoholic fatty liver disease (NAFLD)Liver International, 2013
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitisJournal of Hepatology, 2009
- Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver diseaseBMC Gastroenterology, 2006
- Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver DiseaseGastroenterology, 2005